학술논문
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial
Document Type
Article
Author
Weiss, J.M.; Csoszi, T.; Maglakelidze, M.; Hoyer, R.J.; Beck, J.T.; Domine Gomez, M.; Lowczak, A.; Aljumaily, R.; Rocha Lima, C.M.; Boccia, R.V.; Hanna, W.; Nikolinakos, P.; Chiu, V.K.; Owonikoko, T.K.; Schuster, S.R.; Hussein, M.A.; Richards, D.A.; Sawrycki, P.; Bulat, I.; Hamm, J.T.; Hart, L.L.; Adler, S.; Antal, J.M.; Lai, A.Y.; Sorrentino, J.A.; Yang, Z.; Malik, R.K.; Morris, S.R.; Roberts, P.J.; Dragnev, K.H.
Source
In Annals of Oncology October 2019 30(10):1613-1621
Subject
Language
ISSN
0923-7534